ABEO - Abeona Therapeutics Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5382.82M
Enterprise Value 3307.26M
Trailing P/E N/A
Forward P/E 1-5.17
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)127.69
Price/Book (mrq)2.85
Enterprise Value/Revenue 3102.49
Enterprise Value/EBITDA 6-5.51

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018


Profit Margin 0.00%
Operating Margin (ttm)-1,940.16%

Management Effectiveness

Return on Assets (ttm)-20.59%
Return on Equity (ttm)-37.27%

Income Statement

Revenue (ttm)3M
Revenue Per Share (ttm)0.06
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -55.81M
Net Income Avi to Common (ttm)-56.67M
Diluted EPS (ttm)-1.19
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)84.97M
Total Cash Per Share (mrq)1.77
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.36
Book Value Per Share (mrq)2.80

Cash Flow Statement

Operating Cash Flow (ttm)-39.11M
Levered Free Cash Flow (ttm)-30.92M

Trading Information

Stock Price History

Beta (3Y Monthly) 0.92
52-Week Change 3-59.10%
S&P500 52-Week Change 38.62%
52 Week High 322.00
52 Week Low 36.26
50-Day Moving Average 37.61
200-Day Moving Average 37.93

Share Statistics

Avg Vol (3 month) 3401.7k
Avg Vol (10 day) 3502.05k
Shares Outstanding 548.09M
Float 29.46M
% Held by Insiders 133.45%
% Held by Institutions 168.66%
Shares Short (Mar 29, 2019) 48.1M
Short Ratio (Mar 29, 2019) 419.79
Short % of Float (Mar 29, 2019) 430.68%
Short % of Shares Outstanding (Mar 29, 2019) 416.90%
Shares Short (prior month Feb 28, 2019) 48.02M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 250/1
Last Split Date 3Oct 24, 2014